Correlation Studies Of Mobility Among Patients With Coronary Heart Disease Combined Abnormal Glucose Metabolism

Objective: This research through to the coronary heart disease patients with impairedglucose tolerance test, screening the patients with coronary heart disease with abnormalglucose metabolism, and to study the clinical relevance of these patients, through theobjective indicators, knowledge of blood glucose in patients with coronary heart disease andthe distribution characteristics of the correlation of coronary heart disease risk factors, andanalyzed the influence of the sugar metabolic abnormalities in patients with coronary heartdisease, clear the importance of detecting glucose tolerance, explore the syndrome factors,risk factors and coronary heart disease combined the relationship between the patients withabnormal glucose metabolism, provide a reference basis for clinical diagnosis and treatment.Methods: In coronary heart disease diagnosis standard of all of our hospital in2012hospitalized patients with continuous was selected as the research object, collects1266caseseffectively. Ever diagnosed with diabetes,268cases, not diagnose diabetes,998cases ofcoronary heart disease patients with oral glucose tolerance test (OGTT), and detect the bodymass index (BMI), blood pressure, blood fat, TCM syndrome types, tongue coating, pulsecondition and risk factors. Use SPSS13.0statistical software for data analysis, statistics ofTCM syndrome and related factors of abnormal glucose metabolism associated with coronaryheart disease.Results:1, A total of998patients with coronary heart disease, detected a total of466patientswith abnormal glucose metabolism, including fasting glucose damage, there were124cases(12.24%),228cases of patients with reduced glucose tolerance, accounted for22.85%,114patients with newly diagnosed with diabetes, accounting for11.42%, more than540bloodglucose within the normal range. Can draw from this, if it is not of coronary heart diseasepatients with OGTT test, there will be46.69%of the patients with abnormal glucosemetabolism may therefore go undiagnosed, if simple detection of fasting plasma glucose,misdiagnosis and34.27%patients with abnormal blood glucose.2, The merger of coronary heart disease in patients with abnormal glucose metabolism, master of traditional Chinese medicine with qi and Yin deficiency, phlegm blood stasisblocking collaterals, qi and Yin deficiency, blood stasis blocking collaterals is given priorityto, respectively,149cases (31.97%),121cases (25.97%), followed by the type of qideficiency blood stasis, phlegm turbidity resistance, qi deficiency and blood stasis, phlegmand blood stasis alternating knot, deficiency of Yin and Yang, phlegm blood stasis blockingcollaterals, heart kidney Yang deficiency, and qi stagnation and blood stasis, qi and Yindeficiency, kidney Yin deficiency, qi deficiency and qi stagnation, phlegm and blood stasis.By chi-square test, coronary heart disease combined with abnormal glucose metabolismgroup glucose metabolism was statistically significant in the card type distribution of thenormal group (X~2=41.012, P=0.000<0.05), coronary heart disease combined abnormalglucose metabolism group mainly both qi and Yin deficiency, phlegm blood stasis blockingcollaterals syndrome is given priority to, and sugar metabolism normal group with qi and Yindeficiency, blood stasis blocking collaterals syndrome is given priority to, sugar metabolicabnormalities carry more have phlegm turbidity, and more than simple coronary heart diseasegroup with blood stasis.3, Sugar metabolic abnormalities in patients with coronary heart disease merger exceptno clear history of176cases,290patients in the medical history form than, how to, in lessstable angina, arrhythmia, chronic myocardial infarction, unstable angina, and ischemiccardiomyopathy. Via analysis of variance, the mean differences were6.7,6.3,9.7,2.3,52,19.7, with stable angina and arrhythmia of the main aspects, in0.05inspection must water,in addition to the difference of DM and IGT has no statistical significance, other two havedifferences. Coronary heart disease combined glucose metabolism abnormality and coronaryheart disease between normal glucose metabolism group has no statistical significance in thehistory (X~2=5.375, P=5.375>0.05).4, This study of coronary heart disease combined sugar metabolic abnormalities inpatients with risk factors ratio from high to low in turn is: high blood pressure, obesity,hyperlipidemia, smoking, family history. By the chi-square test (X~2=23.053, P=0.011<0.05).Via analysis of variance, the mean differences were3.0,42.7,87.0,85.0,37.7,9.3, the majorrisk factors for high blood pressure, obesity, smoking status, in0.05inspection must water,besides no statistically significant IFG and DM, other two have differences. And coronary heart disease combined with abnormal glucose metabolism group of sugar metabolism innormal group in a single risk factor, by chi-square test, there was statistical significance (X~2=0.387, P=0.000<0.05), with hypertension or obesity in patients with coronary heart disease,easily and with abnormal glucose metabolism. In double factor and multiple factorscomparison, coronary heart disease combined sugar metabolic abnormalities were higher thannormal glucose metabolism group coronary heart disease, visible risk factors, the more thegreater the incidence of coronary heart disease combined glucose metabolism, but nostatistical significance between them.5, Institute showed that coronary heart disease merger in patients with abnormal glucosetolerance, blood pressure control in terms of a single drug, CCB drugs dominated, and interms of combined use of drugs, most associated with beta blockers used more. By analysis ofvariance, the mean differences were4.0,4.0,27.0,3.0,1.0,0.6,2.3,0.7,4.3, the CCBaccount for main aspects. Coronary heart disease combined glucose metabolism abnormalityand coronary heart disease between normal glucose metabolism in past drug use, no statisticalsignificance (X~2=11.389, P=11.389>0.05), shows that in the past medicine has not cause yourblood sugar levels to rise.Conclusion:1, Patients with coronary heart disease should attach great importance to clinicalapplication of glucose tolerance test screening, early detection rate and detection rate in orderto improve the blood glucose abnormalities, and promptly take effective interventionmeasures to prevent the further development of the disease, regular testing related clinicalindicators, provide effective theory basis for clinical, guiding treatment.2, With coronary heart disease and abnormal glucose metabolism mainly both qi and Yindeficiency, phlegm blood stasis blocking collaterals syndrome is given priority to, sugarmetabolism in normal group and coronary heart disease with qi and Yin deficiency, bloodstasis blocking collaterals syndrome is given priority to, sugar metabolic abnormalities carrymore have phlegm turbidity, simply carry with coronary heart disease and blood stasis.3, Age, smoking, obesity, hypertension and hyperlipidemia are factors has a significanteffect on atherosclerosis, single risk factors are mainly composed of high blood pressure,obesity, and merge the more risk factors, the higher the prevalence of coronary heart disease combined sugar metabolic abnormalities, the patients with risk factors should be given a highdegree of attention, prevention of recurrent cardiovascular events.